tiprankstipranks
Trending News
More News >
Ascelia Pharma AB (DE:7ZA)
:7ZA
Germany Market

Ascelia Pharma AB (7ZA) Financial Statements

Compare
2 Followers

Ascelia Pharma AB Financial Overview

Ascelia Pharma AB's market cap is currently €27.64M. The company's EPS TTM is €-0.116; its P/E ratio is ―; Ascelia Pharma AB is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is €-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr -1.05Mkr -3.89Mkr -8.72Mkr -825.00Kkr -62.00K
Operating Incomekr -110.91Mkr -147.01Mkr -137.95Mkr -93.43Mkr -36.74M
EBITDAkr -108.56Mkr -132.06Mkr -128.42Mkr -98.91Mkr -39.93M
Net Incomekr -109.29Mkr -131.22Mkr -125.90Mkr -98.70Mkr -39.91M
Balance Sheet
Cash & Short-Term Investmentskr 21.86Mkr 149.56Mkr 261.60Mkr 184.69Mkr 184.23M
Total Assetskr 87.07Mkr 218.57Mkr 333.49Mkr 255.37Mkr 250.23M
Total Debtkr 1.06Mkr 484.00Kkr 1.66Mkr 1.78Mkr 96.00K
Net Debtkr -20.80Mkr -149.07Mkr -259.94Mkr -182.91Mkr -108.42M
Total Liabilitieskr 12.74Mkr 37.71Mkr 25.66Mkr 19.32Mkr 13.16M
Stockholders' Equitykr 74.33Mkr 180.86Mkr 307.83Mkr 236.06Mkr 237.06M
Cash Flow
Free Cash Flowkr -126.79Mkr -125.33Mkr -116.60Mkr -85.92Mkr -36.92M
Operating Cash Flowkr -126.79Mkr -125.26Mkr -116.56Mkr -85.53Mkr -36.92M
Investing Cash Flowkr 46.00Kkr -65.00Kkr -38.00Kkr 75.99Mkr -75.00K
Financing Cash Flowkr -936.00Kkr -1.10Kkr 184.87Mkr 92.72Mkr -60.00K
Currency in SEK

Ascelia Pharma AB Earnings and Revenue History

Ascelia Pharma AB Debt to Assets

Ascelia Pharma AB Cash Flow

Ascelia Pharma AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis